Drug discontinued-text Specifically, the following presentations will no longer be available: 125mg/5mL; 100mL bottles (anticipated final date of availability: April 1, 2018), 250mg/5mL; 50mL bottles ...
GlaxoSmithKline Plc said on Wednesday it had filed for a preliminary injunction seeking to prevent Canada's Apotex from selling a generic version of GSK's Ceftin antibiotic in the US market. Apotex ...
Ranbaxy Laboratories Ltd has received approval from the US Food and Drug Administration to manufacture and market cefuroxime axetil for oral suspension USP, 125 mg / 5mL and 250 mg / 5mL, which will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results